QA: Avadel Pharmaceuticals PLC in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001012477_2025_Avadel_Pharmaceuticals_PLC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001012477, Avadel Pharmaceuticals PLC

  xvar xval
0 AssetsCurrent 134,208,000
1 IntangibleAssetsNetIncludingGoodwill 16,836,000
2 PropertyPlantAndEquipmentNet 453,000
3 remainder_Assets 12,739,000
4 LiabilitiesCurrent 48,834,000
5 LiabilitiesNoncurrent 6,305,000
6 remainder_Liabilities 35,249,000
7 CostOfGoodsAndServicesSold 28,175,959
8 SellingGeneralAndAdministrativeExpense 200,861,723
9 ResearchAndDevelopmentExpense 15,742,712
10 remainder_Expenses 10,462,725
11 remainder_Revenues 184,060,436
12 remainder_NetIncome -4,210,904
13 remainder_ComprehensiveNetIncome 83,592
  yvar yval
0 Assets 164,236,000
1 Liabilities 90,388,000
2 Expenses 255,243,119
3 Revenues 184,060,436
4 StockholdersEquity 73,848,000
5 NetIncome -75,393,587
6 ComprehensiveNetIncome -75,351,791
7 BaseVar 349,111,026
8 EconomicCapitalRatiobeforeLimitedLiability 0.673
9 EconomicCapitalRatio 2.03

Edgar->Model Mapping

Feature Distribution

Change over Time